UK: Company finds cure for Pierce's disease

By Chris Brook-Carter | 24 February 2003

A UK-based chemical company, Ximed Group, is claiming to have found a natural formulation that can successfully eradicate Pierce's disease, the debilitating vine infection that has caused millions of dollars of damage to the US wine industry in recent years. The company specialises in the application of terpene, which is a naturally occurring low toxicity botanical substance, in agriculture and pharmacy. And it is this botanical, Ximed says, that has been adapted to cure the insect transmitted disease.

just-drinks articles are only available to registered users and members.

Join now for increased access

There are various access options to choose from. All provide instant access to the latest news, insight and expert analysis.

If you’re already a member, login here.

A UK-based chemical company, Ximed Group, is claiming to have found a natural formulation that can successfully eradicate Pierce's disease, the debilitating vine infection that has caused millions of dollars of damage to the US wine industry in recent years. The company specialises in the application of terpene, which is a naturally occurring low toxicity botanical substance, in agriculture and pharmacy. And it is this botanical, Ximed says, that has been adapted to cure the insect transmitted disease.

  • Unlimited access to all the latest global beverage news and insight
  • Expert analysis that puts the news into context
  • Exclusive interviews with leading industry figures
  • Monthly management briefings with detailed analysis on hot topics
  • Personalised RSS feeds and email newsletters
  • 10-year archive of news, insight and intelligence
  • Discounts on just-drinks market research
  • Plus much more

If you’re already a member, login here

Not what you were looking for?

Search just-drinks:

just-drinks tagline

Not a member? Join here

Decrease font sizeDecrease font sizeDecrease font size Increase font sizeIncrease font sizeIncrease font size Comment on this article Email this to a friend Print this page